Position in AZN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$39,625,081
-$12,343,769 QoQ
Shares Held
208,971
-20.7% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
1.23%
of 13F equity value
Holder Rank
#175
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TRILLIUM ASSET MANAGEMENT, LLC holds $65,640,925 across 8 Drug Manufacturers - General names. AZN ranks #1 (60.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
This page
|
208,971 | $39,625,081 | |
| 2 | MRK |
Merck & Co., Inc.
|
87,017 | $11,181,684 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
75,118 | $9,490,408 | |
| 4 | JNJ |
Johnson & Johnson
|
11,314 | $2,873,416 | |
| 5 | NVO |
Novo Nordisk A S
|
19,689 | $943,890 | |
| 6 | ABBV |
AbbVie Inc.
|
2,843 | $715,412 | |
| 7 | LLY |
ELI LILLY & Co
|
359 | $430,595 | |
| 8 | PFE |
Pfizer Inc
|
15,799 | $380,439 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $39,625,081 | 208,971 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $51,968,850 | 263,507 | Shares | Defined | 2026-05-11 | |
| No filing history on record for this holder in this stock. | ||||||